Successful advisor to private and public life science companies planning and implementing all aspects of strategic, integrated communications programs. Current work focuses on investor and public relations projects, strategic messaging, competitive analysis and positioning, investor event planning, presentations, speech writing and scripting, website development, conference and publication strategy, corporate branding/rebranding, social media strategy, and crisis communications.

Member of the D&CO team providing strategic communications advisory, corporate positioning, and core messaging for websites, PPTs, and other projects.

Providing comprehensive investor relations, public relations, and corporate communications services and advisory to the life science industry.

- Ghost wrote three academic chapters – Brands & Brand Equity, Global Marketing, and Customer Centricity - for the Higher Education MBA market, and assisted with a reading on Marketing Communications. - Created an educational prototype product to highlight the Historical Collections in Harvard Business School's Baker Library - History of the U.S. Retail Market.

Responsible for strategy development and execution of investor- and media-related activities, corporate communications and internal communications. In this newly created position: honed key messages, developed strategy and tactics for reaching key buyside, sellside, and media targets; developed content and led design of new corporate fact sheet, antibiotic backgrounder, and the company’s first annual report; created a cross-functional company committee focused on improving internal corporate dialogue. Managed relationships with two external agencies. Performed extensive competitive analysis.

Successful advisor to private and public companies planning and implementing all aspects of strategic, integrated investor relations, public relations, and communications programs. Worked independently and contracted with multiple life science communications agencies focusing on investor and public relations projects, strategic messaging, competitive analysis and positioning, capital advisory, IPO management, slide presentations, speech writing and scripting, website development, event planning, corporate branding and reputation management, employee communications and corporate culture, community affairs, public affairs, digital media strategy, and crisis communications. Freelance writer and editor focusing on websites, educational content, white papers, grant proposals, and development materials.

Responsible for the creation of Cubist’s Corporate Communications department, strategy and programs and for all investor- and media-related activities, corporate communications, internal communications, and community affairs. As primary spokesperson, effectively communicated through multiple crises, changes in management, FDA filing, delay, approval and launch of the company’s flagship product, and through both debt and equity financings. Managed internal team as well as relationships with two external agencies. Member of both the company’s Disclosure and Document Clearance Committees.

Provided comprehensive financial and communication advisory services to small-cap healthcare and information technology companies. Communications responsibilities included creation and editing of all client press releases, marketing and other communications documents; extensive analyst, investor and media contact; crisis communications advisory; website design, development and competitive analysis. Investment banking responsibilities included equity research on select group of companies; competitive and industry analyses; advisory on and creation of private business plans; participant in private placement transactions and general strategic corporate finance advisory.

Responsible for the creation of Cadus’ Corporate Communications department, strategy and programs, and for all investor- and media-related activities. Served as primary company spokesperson as well as provided strategic business advisory to senior management, competitive analysis, and modeling and analysis of several proposed M&A transactions. Gained valuable experience dealing with challenging Board of Directors. Created and maintained corporate website.

Equity Research analyst covering the mid-cap and specialty pharmaceutical sectors; participated in Merrill Lynch-led equity offerings and SWORD transactions; scheduled and coordinated companies and analysts for Merrill Lynch’s Annual Global Drug & Biotechnology Conference.